Patents by Inventor Jonathan M. Benns

Jonathan M. Benns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lysine delivery systems for blood coagulation
    Patent number: 10046150
    Abstract: A blood coagulating device can include an absorbent body; and a hemostatic lysine composition associated with the body. The body can have a cylindrical or conical member having a first end having the hemostatic composition, the first end being configured for insertion into a nasal passageway. A method for coagulating blood can include providing a powdered hemostatic lysine composition; and applying the powdered hemostatic lysine composition to blood so as to cause the blood to coagulate and form a clot. The coagulation can occur in a nasal passageway away from a blood vessel. The method can include providing at least one absorbent member having the powdered hemostatic lysine composition; and applying the at least one absorbent member to the blood so that the powdered hemostatic lysine composition causes the blood to coagulate and clot.
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: August 14, 2018
    Assignee: Park City Bio, LLC
    Inventors: Jonathan M. Benns, Matthew C. Lawyer
  • LYSINE DELIVERY SYSTEMS FOR BLOOD COAGULATION
    Publication number: 20170361075
    Abstract: A blood coagulating device can include an absorbent body; and a hemostatic lysine composition associated with the body. The body can have a cylindrical or conical member having a first end having the hemostatic composition, the first end being configured for insertion into a nasal passageway. A method for coagulating blood can include providing a powdered hemostatic lysine composition; and applying the powdered hemostatic lysine composition to blood so as to cause the blood to coagulate and form a clot. The coagulation can occur in a nasal passageway away from a blood vessel. The method can include providing at least one absorbent member having the powdered hemostatic lysine composition; and applying the at least one absorbent member to the blood so that the powdered hemostatic lysine composition causes the blood to coagulate and clot.
    Type: Application
    Filed: September 6, 2017
    Publication date: December 21, 2017
    Inventors: Jonathan M. Benns, Matthew C. Lawyer
  • Lysine delivery systems for blood coagulation
    Patent number: 9757547
    Abstract: A blood coagulating device can include an absorbent body; and a hemostatic lysine composition associated with the body. The body can have a cylindrical or conical member having a first end having the hemostatic composition, the first end being configured for insertion into a nasal passageway. A method for coagulating blood can include providing a powdered hemostatic lysine composition; and applying the powdered hemostatic lysine composition to blood so as to cause the blood to coagulate and form a clot. The coagulation can occur in a nasal passageway away from a blood vessel. The method can include providing at least one absorbent member having the powdered hemostatic lysine composition; and applying the at least one absorbent member to the blood so that the powdered hemostatic lysine composition causes the blood to coagulate and clot.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: September 12, 2017
    Assignee: Park City Bio, LLC
    Inventors: Jonathan M. Benns, Matthew C. Lawyer
  • LYSINE DELIVERY SYSTEMS FOR BLOOD COAGULATION
    Publication number: 20140329902
    Abstract: A blood coagulating device can include an absorbent body; and a hemostatic lysine composition associated with the body. The body can have a cylindrical or conical member having a first end having the hemostatic composition, the first end being configured for insertion into a nasal passageway. A method for coagulating blood can include providing a powdered hemostatic lysine composition; and applying the powdered hemostatic lysine composition to blood so as to cause the blood to coagulate and form a clot. The coagulation can occur in a nasal passageway away from a blood vessel. The method can include providing at least one absorbent member having the powdered hemostatic lysine composition; and applying the at least one absorbent member to the blood so that the powdered hemostatic lysine composition causes the blood to coagulate and clot.
    Type: Application
    Filed: May 2, 2014
    Publication date: November 6, 2014
    Applicant: Park City Bio, LLC
    Inventors: Jonathan M. Benns, Matthew C. Lawyer